Capital Analysts LLC Portfolio holdings
Capital Analysts is a Lincoln Investment company that provides a ready-made wealth management platform to independent financial professionals who serve affluent clients. Capital Analysts dates from 2012 and belongs to Lincoln Investment Capital Holdings; Lincoln Investment Planning, a brokerage and advisory firm under the same ownership, handles brokerage services for it and its advisors. Those advisors work across the United States as independent contractors, not employees. Their clients include individuals, high net worth individuals, trusts, foundations, businesses and charities, and Capital Analysts also offers its institutional advisory services to other advisers and trust companies. The portfolios it builds aim to be diversified and rest on asset allocation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$24.6M |
| 2 |
Goldman Sachs ETF Trust Goldman Sachs S&P 500 Premium Income ETF
GPIX
|
+$16.4M |
| 3 |
Fidelity Total Bond ETF
FBND
|
+$16.1M |
| 4 |
iShares Systematic Alternatives Active ETF
IALT
|
+$16M |
| 5 |
iShares Core Universal USD Bond ETF
IUSB
|
+$11.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$7.72M |
| 2 |
Citigroup
C
|
+$7.28M |
| 3 |
iShares Gold Trust
IAU
|
+$6.25M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$6.23M |
| 5 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$6.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 76.75% |
| 2 | Technology | 5.6% |
| 3 | Financials | 4.52% |
| 4 | Industrials | 2.67% |
| 5 | Healthcare | 2.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
951
Terreno Realty
TRNO
$7.39B
| $60K | ﹤0.01% |
919
-174
| -16% | -$11.4K |
2015 Q1
45 quarters
|
|
952
NEOS Enhanced Income Credit Select ETF
HYBI
$218M
| $60K | ﹤0.01% |
1,216
-14
| -1% | -$692 |
2025 Q2
4 quarters
|
|
953
Bank of Montreal
BMO
$121B
| $59K | ﹤0.01% |
333
+2
| +0.6% | +$314 |
2021 Q1
21 quarters
|
|
954
Schwab Fundamental International Small Company Index ETF
FNDC
$3.06B
| $59K | ﹤0.01% |
1,203
-858
| -42% | -$42.3K |
2024 Q2
8 quarters
|
|
955
Kite Realty
KRG
$5.07B
| $59K | ﹤0.01% |
2,049
-399
| -16% | -$10.7K |
2021 Q3
19 quarters
|
|
956
Vertex Pharmaceuticals
VRTX
$140B
| $59K | ﹤0.01% |
119
| – | – |
2019 Q1
29 quarters
|
|
957
Cencora
COR
$66B
| $58K | ﹤0.01% |
206
+175
| +565% | +$50.4K |
2017 Q2
36 quarters
|
|
958
JPMorgan Global Select Equity ETF
JGLO
$6.24B
| $58K | ﹤0.01% |
811
+404
| +99% | +$28.3K |
2025 Q4
2 quarters
|
|
959
Innovator US Equity Power Buffer ETF March
PMAR
$742M
| $58K | ﹤0.01% |
1,212
| – | – |
2023 Q1
13 quarters
|
|
960
Sun Life Financial
SLF
$41B
| $58K | ﹤0.01% |
+738
| New | +$53.1K |
2026 Q2
0 quarters
|
|
961
First Trust Nasdaq Semiconductor ETF
FTXL
$1B
| $57K | ﹤0.01% |
200
| – | – |
2025 Q1
5 quarters
|
|
962
Royal Bank of Canada
RY
$283B
| $57K | ﹤0.01% |
274
+2
| +0.7% | +$371 |
2020 Q4
22 quarters
|
|
963
Veralto
VLTO
$28.7B
| $57K | ﹤0.01% |
648
-126
| -16% | -$10.9K |
2023 Q4
10 quarters
|
|
964
First Trust NYSE Arca Biotechnology Index Fund
FBT
$3.05B
| $56K | ﹤0.01% |
227
+64
| +39% | +$13.8K |
2025 Q1
5 quarters
|
|
965
Frontdoor
FTDR
$6.81B
| $56K | ﹤0.01% |
716
| – | – |
2020 Q3
23 quarters
|
|
966
Iris Energy
IREN
$9.09B
| $56K | ﹤0.01% |
1,214
+14
| +1% | +$728 |
2025 Q2
4 quarters
|
|
967
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.17B
| $56K | ﹤0.01% |
168
-17
| -9% | -$4.87K |
2023 Q1
13 quarters
|
|
968
Cambria Tail Risk ETF
TAIL
$163M
| $56K | ﹤0.01% |
5,257
| – | – |
2025 Q2
4 quarters
|
|
|
969
Zoetis
ZTS
$33.4B
| $56K | ﹤0.01% |
787
-81,991
| -99% | -$7.72M |
2019 Q1
29 quarters
|
|
970
Invesco Dorsey Wright Consumer Staples Momentum ETF
PSL
$82.3M
| $55K | ﹤0.01% |
493
-192
| -28% | -$21.2K |
2023 Q3
11 quarters
|
|
971
Virtus Stone Harbor Emerging Markets High Yield Bond ETF
VEMY
$35.6M
| $55K | ﹤0.01% |
1,907
+68
| +4% | +$1.95K |
2026 Q1
1 quarter
|
|
972
FT Vest Nasdaq-100 Conservative Buffer ETF - July
QCJL
$102M
| $55K | ﹤0.01% |
2,214
| – | – |
2025 Q1
5 quarters
|
|
973
Innovator Equity Defined Protection ETF - 1 Yr November
ZNOV
$106M
| $55K | ﹤0.01% |
2,004
| – | – |
2024 Q4
6 quarters
|
|
974
Alerian MLP ETF
AMLP
$12.2B
| $54K | ﹤0.01% |
1,042
+1
| +0.1% | +$52 |
2023 Q1
13 quarters
|
|
975
Invesco
IVZ
$12.7B
| $54K | ﹤0.01% |
2,038
+2
| +0.1% | +$53 |
2021 Q2
20 quarters
|
|
Similar funds
Capital Analysts LLC's Q2 2026 Portfolio in Review
As of Q2 2026, Capital Analysts LLC held 1,612 positions worth $4.34B, up 14% from $3.81B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Capital Analysts LLC deployed $223M of net new capital in Q2 2026, opening 75 new positions and adding to 544 existing holdings. Its largest new stake was iShares Systematic Alternatives Active ETF: 571,327 shares worth $16M.
By sector, the portfolio is most concentrated in Miscellaneous at 77% of assets, up from 75% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Zoetis, an estimated $7.72M trimmed.
- Capital Analysts LLC's largest Q2 2026 buy was iShares Systematic Alternatives Active ETF: 571,327 shares worth $16M.
- Capital Analysts LLC added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $24.6M increase.
- Capital Analysts LLC's biggest Q2 2026 reduction was Zoetis, cutting an estimated $7.72M.
- Capital Analysts LLC fully exited Hershey in Q2 2026, selling an estimated $113K.
- Capital Analysts LLC's ten largest holdings make up 30% of its $4.34B portfolio in Q2 2026.
- Capital Analysts LLC opened 75 new positions and closed 76 in Q2 2026.
- Capital Analysts LLC's portfolio value rose 14% quarter-over-quarter to $4.34B.
Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.